Amman, Oct. 8 (Petra) -- Dr. Rimal Mousa, an associate professor of health economics and public health at the University of Jordan’s Faculty of Pharmacy, has received the 2026 LMIC (Low- and Middle-Income Countries) Health Economics Outcomes Research Excellence Award fromInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR), in recognition of her pioneering contributions to the field at the national and regional levels.

According to a university statement issued Thursday, Mousa was honored during ISPOR’s annual conference in Philadelphia, United States, which brought together leading experts in pharmacoeconomics and health outcomes research.

The statement said Mousa is among the early specialists to advance health economics in Jordan and the region. Her work has included incorporating advanced economic modeling into academic teaching and supporting evidence-based decision-making in the healthcare sector. She also contributed to establishing the region’s first specialized academic program in health economics and health policy.

Mousa further helped develop an evidence-based framework for economic evaluation to support negotiations with pharmaceutical companies over medicine prices through her membership on the Drug Pricing Committee at the Jordan Food and Drug Administration. She has also advised several national and international institutions and pharmaceutical companies on preparing health technology assessment dossiers.

She played a central role in developing Jordan’s first national guide for health technology assessment, contributing to greater reliance on scientific evidence in health policymaking and healthcare decision-making.

The recognition underscores the University of Jordan’s growing academic and research presence in the health sector and highlights the contributions of its faculty to advancing healthcare practices and policies both nationally and internationally.

//Petra//WH

08/10/2026 11:29:08